New approaches and highlights from SIOG 2019

The young SIOG interest group

The importance of proper geriatric classification for haematological malignancies

The many faces of geriatric oncology

Realising the potential of biosimilars

Comment: Use of biosimilar monoclonal antibodies in the clinic

Comment: Immunogenicity of biosimilars

Simplifying molecular subtypes of metastatic gastric cancer

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma

Optimal timing of radiotherapy following radical prostatectomy

Using PARP inhibitors to improve quality of life for patients with metastatic breast cancer

Melanoma highlights from ESMO 2019